Movement Alert｜Twist Bioscience Corp Falls 5.34% in Regular Trading, Rating Initiations and Lilly TuneLab Collaboration Remain in Focus

Market Focus11-04

On November 4, Twist Bioscience Corp fell 5.34% in Regular Trading, trading at $132.89 per share, with turnover of $59.90 million.

The move came as the market continued to digest recent rating initiations and the company’s collaboration with Eli Lilly’s TuneLab platform, while public information did not show a stronger new catalyst and trading volatility intensified.

Recent developments show Jefferies initiated coverage with a Hold rating and a $150 price target, while UBS initiated with a Neutral rating and a $144 price target. Separately, Twist Bioscience Corp said it would provide antibody characterization data services to Lilly TuneLab, an AI/ML drug discovery platform created by Eli Lilly, with the collaboration focused on antibody drug discovery. Earlier market attention had also highlighted AI drug discovery as a potential order growth driver, but the latest trading narrative points more to continued digestion of prior catalysts than to fresh incremental news.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment